https://www.selleckchem.com/pr....oducts/gusacitinib.h
8, CI 95% 1.3-5.9), and those with a higher financial impact (OR 2.3, CI 95% 1.3-4.3) reported greater difficulties managing AI. Patients were more likely to report a higher anxiety score (≥8) if they found managing AI challenging during the pandemic (OR 3.0, CI 95% 1.3-6.9), and had lower Physical Component Summary (OR 4.9, CI 95% 2.2-11. and Mental Component Summary (OR 4.1, CI 95% 1.8-9.5) scores prior to the pandemic. A third of patients with AI reported difficulties with management of AI during the pandemic, particularly in y
Like
Comment
Share
